CC-90010 (compound 1) 是可逆的、具有口服活性的 BET 抑制剂。CC-90010 正用于晚期实体肿瘤的研究。
货号:ajcx33508
CAS:1706738-98-8
分子式:C21H21NO4S
分子量：383.46
溶解度:DMSO : 50 mg/mL (130.39 mM; Need ultrasonic)
纯度：98%
存储：Store at -20°C
库存：现货

Background:

CC-90010 (compound 1) is a reversible and orally active BET inhibitor. CC-90010 is applied in the study for advanced solid tumors[1][2].

[1]. CELGENE QUANTICEL RESEARCH, INC. PROCESS FOR THE PREPARATION OF BROMODOMAIN INHIBITOR. Patent. WO2020023438.
[2]. V. Moreno, et al. CC-90010, a reversible, oral bromodomain and extra-terminal (BET) inhibitor in patients (Pts) with advanced solid tumours (STs) and relapsed/refractory (R/R) non-Hodgkin lymphoma: Updated results of a phase I study.